Cencora Announces Financial Leadership Transition

Core Viewpoint - Cencora, Inc. announces the retirement of James F. Cleary as Executive Vice President and Chief Financial Officer effective June 30, 2026, while reaffirming its fiscal 2026 financial guidance for adjusted diluted EPS in the range of $17.45 to $17.75 [1][3]. Leadership Transition - James F. Cleary has served as CFO since November 2018 and joined Cencora in February 2015 after the acquisition of MWI Veterinary Supply, where he was CEO for over a decade [2]. - The company has engaged an executive search firm to identify potential successors, and Cleary will assist in the transition process until the end of 2026 [1][3]. Financial Guidance - Cencora reaffirms its adjusted diluted EPS guidance for fiscal year 2026, maintaining a range of $17.45 to $17.75 [3]. Company Overview - Cencora is a leading global pharmaceutical solutions organization with over 51,000 employees and annual revenue exceeding $300 billion, ranked 10 on the Fortune 500 and 18 on the Global Fortune 500 [4].